Overview
Investors 2
| Date | Name | Website |
| Sign up to see | Sign up to see | Sign up to see |
| VentureLab | venturelab.swiss |
Mentions in press and media 10
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Sep 25, 2024 | Synple chem joins US-based eMolecules | Founded by Benedikt Wanner (Founder & CEO) AND Paula Nichols (Co-founder and CCO) along with their team, Synpl Chem is a pioneering Zurich-based company that specializes in automated chemical synthesis for small molecules drug discover... |
| Jan 20, 2023 | Medtech start-ups enroute to transform the industry | |
| Nov 9, 2022 | The Swiss delegation warms up for Slush 2022 | |
| Apr 22, 2022 | Synple Chem to expand product portfolio | |
| Nov 4, 2021 | Thirteen startups explore East and West Coast expansion opportunities | |
| Oct 1, 2021 | Six winners of the i4Challenge 2021 selected | |
| Jul 26, 2019 | SME Instrument Phase I and phase II funded companies revealed | |
| Feb 11, 2019 | Four InnoBooster-startups to progress towards market entry | |
| Mar 27, 2018 | Schweizer Erfolg in Berlin |
Reviews 0
FAQ about Synple Chem AG
Who has invested in Synple Chem AG?
Parsers VC lists 2 investors of Synple Chem AG, among them VentureLab.
What has the press written about Synple Chem AG?
Parsers VC has collected 10 articles mentioning Synple Chem AG, among them “Synple chem joins US-based eMolecules” (Sep 25, 2024) and “Medtech start-ups enroute to transform the industry” (Jan 20, 2023).
Is Synple Chem AG still active?
Yes, Synple Chem AG is active; its latest activity on Parsers VC dates from Sep 25, 2024.